DG
42
2
ADM
44
2
LYB
20
-2
AMG
54
-4
SNA
58
-2
SPG
53
-3
ES
44
5
MPC
50
-2
STI
16
3
AMZN
58
-2
PX
72
-4
NAVI
38
-3
XYL
66
-4
PFG
50
-3
PLD
41
-9
MAS
62
-2
BMY
51
3
NTRS
72
-2
LNC
49
-4
COF
57
-2
DG
42
2
ADM
44
2
LYB
20
-2
AMG
54
-4
SNA
58
-2
SPG
53
-3
ES
44
5
MPC
50
-2
STI
16
3
AMZN
58
-2
PX
72
-4
NAVI
38
-3
XYL
66
-4
PFG
50
-3
PLD
41
-9
MAS
62
-2
BMY
51
3
NTRS
72
-2
LNC
49
-4
COF
57
-2
Financhill
Back

Apellis Pharmaceuticals Vs. United Therapeutics Industry Stock Comparison

Sell
42

APLS
Apellis Pharmaceuticals

Last Price:
$17.43
Seasonality Move:
5.74%
Buy
62

UTHR
United Therapeutics

Last Price:
$310.20
Seasonality Move:
10.62%
Sell
42
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $18.51. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
United Therapeutics (UTHR) is a Buy

Is United Therapeutics a Buy, Sell or Hold?

  • The current United Therapeutics [UTHR] share price is $309.57. The Score for UTHR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • UTHR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $18.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight buying pressure.

UTHR Stock Price Chart

What is United Therapeutics's stock price today?

  • The United Therapeutics share price today is $309.57
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing slight buying pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.78 Sell
Relative Strength Index (14 RSI): 48.87 Sell
Chaikin Money Flow: 1017688 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.12 - 19.1) Buy
Bollinger Bands (100): (19.64 - 30.18) Sell

UTHR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.91 Buy
Relative Strength Index (14 RSI): 56.39 Buy
Chaikin Money Flow: 139983 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (290.2 - 306.22) Buy
Bollinger Bands (100): (296.98 - 358.74) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.35 Buy
20-day SMA: 18.1 Buy
50-day SMA: 20.42 Sell
200-day SMA: 28.85 Sell
8-day EMA: 17.7 Buy
20-day EMA: 18.21 Buy
50-day EMA: 20.42 Sell
200-day EMA: 29 Sell

UTHR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 305.52 Buy
20-day SMA: 301.17 Buy
50-day SMA: 301.2 Buy
200-day SMA: 342.53 Sell
8-day EMA: 305.31 Buy
20-day EMA: 302.24 Buy
50-day EMA: 307.12 Buy
200-day EMA: 321.99 Sell

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.19 per share, and an increase next year of $1.21 per share.

United Therapeutics Earnings Growth & UTHR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.80 per share, an increase next quarter of $0.13 per share, an increase this year of $2.51 per share, and an increase next year of $1.11 per share.

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

United Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):